Recent research clarifies that while vitamin D intake can reduce cancer and autoimmune disease risk, its effectiveness heavily depends on an individual’s body composition. A study published in JAMA found that people with higher BMIs experience reduced vitamin D circulation, diminishing the potential benefits previously observed in leaner populations.
The VITAL Study Insights
The analysis, a follow-up to the VITAL cohort study, examined the interplay between vitamin D levels, body composition (weight, body fat, BMI, and waist circumference), and disease outcomes. Researchers discovered that vitamin D supplementation yielded significant preventative results only in participants with normal BMIs at the study’s start. These included:
- 24% reduction in cancer incidence
- 42% reduction in cancer mortality
- 22% reduction in autoimmune disease incidence
However, these benefits were less pronounced or absent in overweight or obese individuals. This discrepancy is likely due to reduced vitamin D metabolism and lower circulating levels in those with higher body fat. Adipose tissue sequesters vitamin D, making it less bioavailable for cellular use.
Why Body Composition Matters
The study supports existing evidence showing an inverse relationship between adipose tissue and vitamin D status. This means that higher BMIs may blunt the proactive health benefits of vitamin D supplementation. While maintaining healthy vitamin D levels is still beneficial, the body’s ability to utilize it effectively is crucial.
The Bottom Line
To maximize longevity benefits, achieving and sustaining adequate vitamin D levels is essential. However, body composition significantly influences how much vitamin D your body can actually use. Individuals with higher BMIs may need to address weight management alongside supplementation to fully realize these benefits.
